g****e
发帖数: 1426 | |
g****e
发帖数: 1426 | 2 This stock is quite new and just upgraded to Nasdaq in September(traded at
about 5 at that time). I expect it back to 5 in near term since its CPX-351
will be as first-in line therapy if approved. Also please phase 2b results
is good with 2.4 months advantage in OS compared with Standard care, please
see below for details:
http://www.celatorpharma.com/new/pr_20120605.html
Undiscovered stock with huge potential. Good luck. |
L***B
发帖数: 141 | |
g****e
发帖数: 1426 | 4 1000 shares. Mid term invest. Target 5. |
L***B
发帖数: 141 | |
L***B
发帖数: 141 | |
L***B
发帖数: 141 | 7 huge offer on the ask now |
g****e
发帖数: 1426 | 8 亏废了。它家是作formulation 的。看来市场不太看好它。现在价格在低位，如果破3.
4的话找机会遛。 |
L***B
发帖数: 141 | 9 ouch only 300 shares damn |
